Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lidocaine for Postoperative Analgesia in Hip Fracture Surgery
NCT06865469Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in postoperative pain comparing Dexmedetomidine Arm with Lidocaine Arm (2 arms). Primary endpoint: Pain Score (Numeric Rating Scale) at 24 hours. Planned start May 2025; status: not yet recruiting.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06865469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06865469.